We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.2%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43.6B
AUM Growth
+$2.01B
(+4.8%)
Cap. Flow
+$1.75B
Cap. Flow
% of AUM
4%
Top 10 Holdings %
Top 10 Hldgs %
18.28%
Holding
1,493
New
278
Increased
387
Reduced
400
Closed
399
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$674M |
| 2 |
IBM
IBM
|
+$408M |
| 3 |
Toronto Dominion Bank
TD
|
+$392M |
| 4 |
Biogen
BIIB
|
+$340M |
| 5 |
Boeing
BA
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$366M |
| 2 |
CVS Health
CVS
|
+$350M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$333M |
| 4 |
TSMC
TSM
|
+$323M |
| 5 |
Merck
MRK
|
+$283M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.47% |
| 2 | Healthcare | 17.17% |
| 3 | Financials | 16.49% |
| 4 | Consumer Discretionary | 12.16% |
| 5 | Industrials | 11.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Euronet Worldwide
EEFT
$2.64B
| $971K | ﹤0.01% |
12,300
-15,839
| -56% | -$1.39M |
|
|
MODN
877
DELISTED
MODEL N, INC.
MODN
| $964K | ﹤0.01% |
+53,394
| New | +$890K |
|
|
DS
878
DELISTED
Drive Shack Inc.
DS
| $964K | ﹤0.01% |
201,591
+16,740
| +9% | +$85.5K |
|
|
HBI
879
DELISTED
Hanesbrands
HBI
| $958K | ﹤0.01% |
52,000
-579,900
| -92% | -$12M |
|
880
Cintas
CTAS
$80.9B
| $955K | ﹤0.01% |
+22,400
| New | +$929K |
|
881
Ovintiv
OVV
$17.6B
| $954K | ﹤0.01% |
+17,360
| New | +$1.03M |
|
882
Stellus Capital Investment Corp
SCM
$243M
| $931K | ﹤0.01% |
80,870
-135,026
| -63% | -$1.63M |
|
883
G-III Apparel Group
GIII
$1.48B
| $916K | ﹤0.01% |
+24,320
| New | +$904K |
|
|
HIVE
884
DELISTED
Aerohive Networks
HIVE
| $916K | ﹤0.01% |
+226,769
| New | +$1.02M |
|
|
NCI
885
DELISTED
Navigant Consulting, Inc.
NCI
| $906K | ﹤0.01% |
+47,100
| New | +$938K |
|
|
SHI
886
DELISTED
Sinopec Shanghai Petrochemical Co., Ltd.
SHI
| $902K | ﹤0.01% |
14,705
-25,687
| -64% | -$1.55M |
|
|
DSPG
887
DELISTED
DSP Group Inc
DSPG
| $895K | ﹤0.01% |
75,879
-21,512
| -22% | -$269K |
|
888
National Presto Industries
NPK
$990M
| $894K | ﹤0.01% |
9,532
-32,023
| -77% | -$3.18M |
|
889
Luxfer Holdings
LXFR
$457M
| $889K | ﹤0.01% |
69,431
-9,133
| -12% | -$130K |
|
|
NATI
890
DELISTED
National Instruments Corp
NATI
| $889K | ﹤0.01% |
17,571
-136,924
| -89% | -$6.67M |
|
|
VIVO
891
DELISTED
Meridian Bioscience Inc
VIVO
| $889K | ﹤0.01% |
62,585
-14,218
| -19% | -$210K |
|
892
Forward Air
FWRD
$638M
| $870K | ﹤0.01% |
16,454
+1,094
| +7% | +$62.3K |
|
893
Itron
ITRI
$4.52B
| $870K | ﹤0.01% |
12,159
-206,466
| -94% | -$14.8M |
|
|
TOWR
894
DELISTED
Tower International, Inc.
TOWR
| $863K | ﹤0.01% |
31,100
+18,100
| +139% | +$521K |
|
895
International Bancshares
IBOC
$4.51B
| $860K | ﹤0.01% |
+22,100
| New | +$897K |
|
896
Ethan Allen Interiors
ETD
$601M
| $856K | ﹤0.01% |
+37,302
| New | +$940K |
|
897
Myriad Genetics
MYGN
$313M
| $835K | ﹤0.01% |
28,248
-29,252
| -51% | -$990K |
|
898
Ternium
TX
$10.8B
| $814K | ﹤0.01% |
+25,055
| New | +$848K |
|
899
Mercury Insurance
MCY
$5.89B
| $794K | ﹤0.01% |
+17,300
| New | +$824K |
|
900
Caleres
CAL
$495M
| $790K | ﹤0.01% |
+23,500
| New | +$721K |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2018 Portfolio in Review
As of Q1 2018, Arrowstreet Capital held 1,493 positions worth $43.6B, up 4.8% from $41.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital deployed $1.75B of net new capital in Q1 2018, opening 278 new positions and adding to 387 existing holdings. Its largest new stake was AB InBev: 2,063,707 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Philip Morris, an estimated $366M trimmed.
- Arrowstreet Capital's largest Q1 2018 buy was AB InBev: 2,063,707 shares worth $227M.
- Arrowstreet Capital added most to AbbVie in Q1 2018, an estimated $674M increase.
- Arrowstreet Capital's biggest Q1 2018 reduction was Philip Morris, cutting an estimated $366M.
- Arrowstreet Capital fully exited iShares MSCI South Korea ETF in Q1 2018, selling an estimated $271M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $43.6B portfolio in Q1 2018.
- Arrowstreet Capital opened 278 new positions and closed 399 in Q1 2018.
- Arrowstreet Capital's portfolio value rose 4.8% quarter-over-quarter to $43.6B.
Based on Arrowstreet Capital's 13F filing for Q1 2018, filed 14 May 2018.